Chair's Opening Remarks - TIL Therapies Summit

Skip to content

Returning November 2026

Ran November 11-13, 2025
Boston, MA

REGISTER INTEREST

Home
About
What’s On
- 2025 Full Event Guide
- 2025 Speakers
Partnership
Take Part
- Register Interest
- Contact Us

Chair’s Opening Remarks

Time: 8:20 am
day: Conference Day Two AM

Speakers:

Lucas Arruda Dr. Lucas Arruda is the Chief Scientific Officer at CuraCell, where he leads the development of CytoPLY and CC 38—an advanced platform and clinical-stage TIL Read more

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences	Beacon
Intelligence

SEARCH

Search

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

Scroll To Top

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.